Europe Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Europe embolization devices market is projected to grow significantly, reaching approximately US$ 1,671.99 million by 2031, up from US$ 886.97 million in 2024, with an estimated compound annual growth rate (CAGR) of 9.6% from 2025 to 2031. This growth is primarily driven by the increasing incidence of colorectal cancer and gastrointestinal bleeding across the region.

Market Overview and Segmentation

The market is divided into several key regions, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany is expected to dominate the market due to its robust healthcare infrastructure and high rates of medical technology adoption. The market is segmented by type, application, and end user:

1. Type: The embolization devices market includes embolization coils, plugs, beads, glues, and other devices. In 2024, embolization coils are anticipated to hold the largest market share, with further segmentation into central and peripheral applications.

2. Application: The market is categorized into neurology, peripheral vascular disease, oncology, urology, and others. Neurology is expected to lead the market in 2024.

3. End User: The end users of embolization devices include hospitals, ambulatory centers, and others, with hospitals accounting for the largest share in 2024.

Market Dynamics

The growth of the embolization devices market in Europe is significantly influenced by the rising prevalence of conditions requiring embolization, such as colorectal cancer. The increasing number of interventional procedures and advancements in medical technology are also contributing to market expansion. Companies in this sector are focusing on geographic expansion, product innovation, and technological advancements to enhance their market presence.

Recent Developments

Several notable product launches and approvals are expected to propel market growth:

In January 2024, Zylox-Tonbridge Medical Technology Co Ltd received marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System. This device is designed for minimally invasive treatment of peripheral arterial embolism and has applications in managing visceral aneurysms and endoleaks from abdominal aortic aneurysms.
In October 2023, Sirtex Medical launched the Lava Liquid Embolic System (LES), which is approved for treating peripheral vascular hemorrhage. This system offers customizable volume and viscosity options, allowing for precise occlusion of target vessels, particularly in challenging anatomical locations.

Country Insights

Germany is the leading country in the European embolization devices market, driven by a strong healthcare system, substantial investments in medical research, and early adoption of minimally invasive technologies. According to GLOBOCAN 2022, Germany reported around 62,544 new colorectal cancer cases in 2022, highlighting the need for effective treatment options. The country’s hospitals are well-equipped for interventional radiology, frequently employing embolization techniques for various conditions, including tumors and vascular malformations.

Germany's healthcare sector benefits from a supportive reimbursement framework that encourages the adoption of innovative procedures. Additionally, the presence of leading academic institutions and research centers fosters collaboration with MedTech companies to advance embolization technologies. For instance, a research team from Charité – University Hospital Berlin received recognition for their study on genicular artery embolization for knee osteoarthritis, showcasing the potential of embolization in diverse medical applications.

Competitive Landscape

Key players in the embolization devices market include Medtronic Plc, Cook Medical Holdings LLC, Stryker Corp, Boston Scientific Corp, Terumo Corp, Johnson & Johnson, Abbott Laboratories, and others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

In conclusion, the Europe embolization devices market is poised for substantial growth, driven by increasing disease prevalence, technological advancements, and strategic initiatives by key players. The focus on innovative treatment options and the expansion of healthcare infrastructure will further support market development in the coming years.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe embolization devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe embolization devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the embolization devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more